These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 11816713

  • 1. A novel monoclonal antibody against the extracellular domain of GPIbbeta modulates vWF mediated platelet adhesion.
    Perrault C, Moog S, Rubinstein E, Santer M, Baas MJ, de la Salle C, Ravanat C, Dambach J, Freund M, Santoso S, Cazenave JP, Lanza F.
    Thromb Haemost; 2001 Nov; 86(5):1238-48. PubMed ID: 11816713
    [Abstract] [Full Text] [Related]

  • 2. A novel missense mutation shows that GPIbbeta has a dual role in controlling the processing and stability of the platelet GPIb-IX adhesion receptor.
    Strassel C, Pasquet JM, Alessi MC, Juhan-Vague I, Chambost H, Combrié R, Nurden P, Bas MJ, De La Salle C, Cazenave JP, Lanza F, Nurden AT.
    Biochemistry; 2003 Apr 22; 42(15):4452-62. PubMed ID: 12693941
    [Abstract] [Full Text] [Related]

  • 3. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y, Zhang W, Yan R, Liao Y, Zhao L, Ruan C, Du X, Dai K.
    Circ Res; 2009 Dec 04; 105(12):1177-85. PubMed ID: 19875727
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of adhesive and signaling functions of the platelet GPIb-V-IX complex by a cell penetrating GPIbalpha peptide.
    David T, Ohlmann P, Eckly A, Moog S, Cazenave JP, Gachet C, Lanza F.
    J Thromb Haemost; 2006 Dec 04; 4(12):2645-55. PubMed ID: 17100656
    [Abstract] [Full Text] [Related]

  • 5. Role of the leucine-rich domain of platelet GPIbalpha in correct post-translational processing--the Nancy I Bernard-Soulier mutation expressed on CHO cells.
    Ulsemer P, Lanza F, Baas MJ, Schwartz A, Ravanat C, Briquel ME, Cranmer S, Jackson S, Cazenave JP, de la Salle C.
    Thromb Haemost; 2000 Jul 04; 84(1):104-11. PubMed ID: 10928479
    [Abstract] [Full Text] [Related]

  • 6. Targeting platelet GPIbβ reduces platelet adhesion, GPIb signaling and thrombin generation and prevents arterial thrombosis.
    Maurer E, Tang C, Schaff M, Bourdon C, Receveur N, Ravanat C, Eckly A, Hechler B, Gachet C, Lanza F, Mangin PH.
    Arterioscler Thromb Vasc Biol; 2013 Jun 04; 33(6):1221-9. PubMed ID: 23559635
    [Abstract] [Full Text] [Related]

  • 7. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N, Schlammadinger A, Vauterin S, Cooper S, Descheemaeker G, Tornai I, Deckmyn H.
    Thromb Haemost; 2001 Apr 04; 85(4):679-85. PubMed ID: 11341505
    [Abstract] [Full Text] [Related]

  • 8. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
    Hoylaerts MF.
    Verh K Acad Geneeskd Belg; 1997 Apr 04; 59(3):161-83. PubMed ID: 9490916
    [Abstract] [Full Text] [Related]

  • 9. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
    Iijima K, Murata M, Nakamura K, Kitaguchi T, Handa M, Watanabe K, Fujimura Y, Yoshioka A, Ikeda Y.
    Biochem Biophys Res Commun; 1997 Apr 28; 233(3):796-800. PubMed ID: 9168936
    [Abstract] [Full Text] [Related]

  • 10. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM, Kasirer-Friede A, Goldsmith HL, Brown EA.
    Thromb Haemost; 1997 Mar 28; 77(3):568-76. PubMed ID: 9066012
    [Abstract] [Full Text] [Related]

  • 11. A template-assembled synthetic protein surface mimetic of the von Willebrand factor A1 domain inhibits botrocetin-induced platelet aggregation.
    Hauert J, Fernandez-Carneado J, Michielin O, Mathieu S, Grell D, Schapira M, Spertini O, Mutter M, Tuchscherer G, Kovacsovics T.
    Chembiochem; 2004 Jun 07; 5(6):856-64. PubMed ID: 15174170
    [Abstract] [Full Text] [Related]

  • 12. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?
    Xu G, Ulrichts H, Vauterin S, De Meyer SF, Deckmyn H, Teng M, Niu L.
    Toxicon; 2005 Apr 07; 45(5):561-70. PubMed ID: 15777951
    [Abstract] [Full Text] [Related]

  • 13. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S, Yamamoto H, Nagano M, Arisaka H, Kayahara T, Yoshimoto R.
    Br J Pharmacol; 1997 Sep 07; 122(1):165-71. PubMed ID: 9298543
    [Abstract] [Full Text] [Related]

  • 14. Glycoprotein (GP) Ib-IX-transfected cells roll on a von Willebrand factor matrix under flow. Importance of the GPib/actin-binding protein (ABP-280) interaction in maintaining adhesion under high shear.
    Cranmer SL, Ulsemer P, Cooke BM, Salem HH, de la Salle C, Lanza F, Jackson SP.
    J Biol Chem; 1999 Mar 05; 274(10):6097-106. PubMed ID: 10037692
    [Abstract] [Full Text] [Related]

  • 15. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA, Smith TM, Cunningham K, Jacob J, DeSilva T, Lin L, Shaw GD, Kriz R, Kelleher KS.
    Biochemistry; 2008 Apr 22; 47(16):4674-82. PubMed ID: 18363340
    [Abstract] [Full Text] [Related]

  • 16. A monoclonal antibody directed against human von Willebrand factor induces type 2B-like alterations.
    Ulrichts H, Harsfalvi J, Bene L, Matko J, Vermylen J, Ajzenberg N, Baruch D, Deckmyn H, Tornai I.
    J Thromb Haemost; 2004 Sep 22; 2(9):1622-8. PubMed ID: 15333040
    [Abstract] [Full Text] [Related]

  • 17. The platelet glycoprotein GPIbbeta intracellular domain participates in von Willebrand factor induced-filopodia formation independently of the Ser 166 phosphorylation site.
    David T, Strassel C, Eckly A, Cazenave JP, Gachet C, Lanza F.
    J Thromb Haemost; 2010 May 22; 8(5):1077-87. PubMed ID: 19694944
    [Abstract] [Full Text] [Related]

  • 18. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
    Martin C, Morales LD, Cruz MA.
    J Thromb Haemost; 2007 Jul 22; 5(7):1363-70. PubMed ID: 17389010
    [Abstract] [Full Text] [Related]

  • 19. Von Willebrand factor present in fibrillar collagen enhances platelet adhesion to collagen and collagen-induced platelet aggregation.
    Bernardo A, Bergeron AL, Sun CW, Guchhait P, Cruz MA, López JA, Dong JF.
    J Thromb Haemost; 2004 Apr 22; 2(4):660-9. PubMed ID: 15102023
    [Abstract] [Full Text] [Related]

  • 20. Molecular genetic analysis of a variant Bernard-Soulier syndrome due to compound heterozygosity for two novel glycoprotein Ibbeta mutations.
    Kunishima S, Sako M, Yamazaki T, Hamaguchi M, Saito H.
    Eur J Haematol; 2006 Dec 22; 77(6):501-12. PubMed ID: 16978236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.